Somatus IPO
Somatus is a healthcare technology company focused on kidney care management and value-based care solutions. The company partners with health plans and providers to improve outcomes for patients with chronic kidney disease while reducing costs. Investors are interested due to the large addressable market in chronic disease management and healthcare cost containment.
What We Know
Somatus has not announced plans for an initial public offering. The healthcare technology company has raised significant funding, including a $375 million Series C round in 2021. Founded in 2017, Somatus has grown rapidly by focusing on kidney care management, which affects millions of Americans and represents substantial healthcare costs. The healthcare technology sector has seen varying IPO performance, with value-based care companies attracting investor interest due to healthcare cost pressures. However, Somatus has not provided any confirmed timeline or indicated immediate plans for going public. The company continues to expand its partnerships with health plans and build out its care management platform.
Frequently Asked Questions
Has Somatus had an IPO?
No, Somatus has not had an IPO and remains privately held. The kidney care management company has raised substantial private funding but has not announced public offering plans.
When is the Somatus IPO date?
Somatus has not announced an IPO date or timeline for going public. The company has not disclosed any confirmed plans for a public offering. Sign up for alerts to stay informed.
How can I buy Somatus stock?
You cannot currently buy Somatus stock as it is a private company. Shares are not traded on public exchanges and would only become available through a future IPO. Sign up for alerts to stay informed.
Stay Updated on the Somatus IPO
Get real-time alerts when Somatus files for an IPO, prices shares, or begins trading.
Get IPO Alerts